6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Relación entre ácidos grasos omega-3/omega-6 presentes en la dieta y enfermedad inflamatoria intestinal: Scoping Review Translated title: Relationship between dietary omega-3/omega-6 fatty acids and inflammatory bowel disease: Scoping Review

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          RESUMEN Introducción La enfermedad inflamatoria intestinal (EII) incluye a la colitis ulcerosa (CU) y la enfermedad de Crohn (EC). Se cree que las grasas dietéticas pueden influir en su desarrollo. Objetivo: Analizar cómo se relaciona el contenido de omega-3 y omega-6 presentes en la dieta de forma natural con el proceso de la EII, tanto en su aparición como en su periodo de remisión. Material y Métodos Fuentes de datos: Se realizaron la búsqueda en las bases de datos Scopus y PubMed. Criterios de elegibilidad: Se incluyeron los estudios publicados entre 2007 y 2017, en español e inglés, diseño cuantitativo y cualitativo sobre el tema de estudio. Se excluyeron los estudios sobre fármacos o suplementos, animales y dieta en otras patologías. Evaluación de los estudios: Los estudios fueron evaluados a través de la Guía CASPe y los objetivos propios del diseño de Scoping Review. Resultados Un total de 14 artículos fueron incluidos. Conclusiones Hay evidencia de que el consumo de omega-3 y omega-6 puede influir en el desarrollo de la EII. Aunque no existen recomendaciones dietéticas definidas para las personas con EII, sería fundamental crear una guía de alimentación para el control de esta patología.

          Translated abstract

          ABSTRACT Introduction Inflammatory bowel disease (IBD) includes ulcerative colitis (UC) and Crohn’s disease (CD). It is believed that diet fats can influence the development of this disease. Objective: To analyze how the content of omega-3 and omega-6 naturally present in the diet is related to the IBD process, both in its appearance and in its remission period. Material and Methods Data sources: The databases Scopus and PubMed were searched. Eligibility criteria: Studies published between 2007 and 2017, in Spanish and English, quantitative and qualitative design on the topic of study were included. Studies on drugs or supplements, animals and diet in other pathologies were excluded. Evaluation of studies: The studies were evaluated through the CASPe Guide and the objectives of the Scoping Review design. Results A total of 14 articles were included. Conclusions There is evidence that consumption of omega-3 and omega-6 may influence the development of IBD. Although there are no defined dietary recommendations for people with IBD, it would be essential to create a dietary guide for the control of this pathology.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

          We conducted a systematic review to determine changes in the worldwide incidence and prevalence of ulcerative colitis (UC) and Crohn's disease (CD) in different regions and with time. We performed a systematic literature search of MEDLINE (1950-2010; 8103 citations) and EMBASE (1980-2010; 4975 citations) to identify studies that were population based, included data that could be used to calculate incidence and prevalence, and reported separate data on UC and/or CD in full manuscripts (n = 260). We evaluated data from 167 studies from Europe (1930-2008), 52 studies from Asia and the Middle East (1950-2008), and 27 studies from North America (1920-2004). Maps were used to present worldwide differences in the incidence and prevalence of inflammatory bowel diseases (IBDs); time trends were determined using joinpoint regression. The highest annual incidence of UC was 24.3 per 100,000 person-years in Europe, 6.3 per 100,000 person-years in Asia and the Middle East, and 19.2 per 100,000 person-years in North America. The highest annual incidence of CD was 12.7 per 100,000 person-years in Europe, 5.0 person-years in Asia and the Middle East, and 20.2 per 100,000 person-years in North America. The highest reported prevalence values for IBD were in Europe (UC, 505 per 100,000 persons; CD, 322 per 100,000 persons) and North America (UC, 249 per 100,000 persons; CD, 319 per 100,000 persons). In time-trend analyses, 75% of CD studies and 60% of UC studies had an increasing incidence of statistical significance (P < .05). Although there are few epidemiologic data from developing countries, the incidence and prevalence of IBD are increasing with time and in different regions around the world, indicating its emergence as a global disease. Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

            The discovery of a series of genetic and serological markers associated with disease susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an integrated classification system involving clinical, serological and genetic parameters. The Working Party has reviewed current clinical classification systems in Crohn’s disease, ulcerative colitis and indeterminate colitis, and provided recommendations for clinical classification in practice. Progress with respect to integrating serological and genetic markers has been examined in detail, and the implications are discussed. While an integrated system is not proposed for clinical use at present, the introduction of a widely acceptable clinical subclassification is strongly advocated, which would allow detailed correlations among serotype, genotype and clinical phenotype to be examined and confirmed in independent cohorts of patients and, thereby, provide a vital foundation for future work.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study.

              Dietary linoleic acid, an n-6 polyunsaturated fatty acid, is metabolised to arachidonic acid, a component of colonocyte membranes. Metabolites of arachidonic acid have pro-inflammatory properties and are increased in the mucosa of patients with ulcerative colitis. The aim of this investigation was to conduct the first prospective cohort study investigating if a high dietary intake of linoleic acid increases the risk of developing incident ulcerative colitis. Dietary data from food frequency questionnaires were available for 203 193 men and women aged 30-74 years, resident in the UK, Sweden, Denmark, Germany or Italy and participating in a prospective cohort study, the European Prospective Investigation into Cancer and Nutrition (EPIC). These participants were followed up for the diagnosis of ulcerative colitis. Each case was matched with four controls and the risk of disease calculated by quartile of intake of linoleic acid adjusted for gender, age, smoking, total energy intake and centre. A total of 126 participants developed ulcerative colitis (47% women) after a median follow-up of 4.0 years (range, 1.7-11.3 years). The highest quartile of intake of linoleic acid was associated with an increased risk of ulcerative colitis (odds ratio (OR) = 2.49, 95% confidence interval (CI) = 1.23 to 5.07, p = 0.01) with a significant trend across quartiles (OR = 1.32 per quartile increase, 95% CI = 1.04 to 1.66, p = 0.02 for trend). The data support a role for dietary linoleic acid in the aetiology of ulcerative colitis. An estimated 30% of cases could be attributed to having dietary intakes higher than the lowest quartile of linoleic acid intake.
                Bookmark

                Author and article information

                Journal
                renhyd
                Revista Española de Nutrición Humana y Dietética
                Rev Esp Nutr Hum Diet
                Academia Española de Nutrición y Dietética (Pamplona, Navarra, Spain )
                2173-1292
                2174-5145
                June 2019
                : 23
                : 2
                : 92-103
                Affiliations
                [1] Valencia orgnameUniversidad de Alicante orgdiv1Facultad de Ciencias de la Salud orgdiv2Departamento de Enfermería Spain
                Article
                S2174-51452019000200092 S2174-5145(19)02300200092
                10.14306/renhyd.23.2.720
                b787fc1f-da19-4e91-8680-9eedc81dc01a

                This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

                History
                : 21 June 2019
                : 16 November 2018
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 48, Pages: 12
                Product

                SciELO Spain

                Categories
                Investigaciones

                Enfermedades Inflamatorias del Intestino,Ácidos Grasos Omega-3,Diet Therapy,Diet,Ácidos Grasos Omega-6,Dietoterapia,Fatty Acids, Omega-6,Dieta,Inflammatory Bowel Diseases,Fatty Acids, Omega-3

                Comments

                Comment on this article